AI assistant
Sending…
Swedish Orphan Biovitrum — Major Shareholding Notification 2012
May 25, 2012
2974_iss_2012-05-25_fd26cb91-17d3-4e92-a3a0-db857cf89b59.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Swedish Orphan Biovitrum AB (publ)
Holder
FMR LLC
Instrument
| Instrument | Ordinary Shares SE0000872095 |
|---|---|
| Before the transaction | |
| Shares | 13,199,535 |
| Voting rights | 13,199,535 |
| Transaction | |
| Reason for major shareholding notification Buy | |
| Date | 24/05/2012 |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 13,343,431 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 13,343,431 |
| Percentage | |
| Directly held shares | 4.99 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 5.03 % |
Resulting distribution of total holdings
| Percentage of voting | Number of underlying |
|---|---|
| rights: | shares: |
Shares
| Instruments - FITA Ch. 4, section 2, first | ||
|---|---|---|
| paragraph, line 2 | ||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
-
Physically settled
-
Cash settled
Total
Chain of controlling companies
| Voting rights % Voting rights Company | ||||
|---|---|---|---|---|
| 8,258,378 3.11 | Fidelity Management & Research Company | |||
| 2,629,400 0.99 | Pyramis Global Advisors LLC | |||
| 2,455,653 0.93 | Pyramis Global Advisors Trust Company | |||
| Group total holdings | ||||
| Voting rights | 13,343,431 | |||
| Percentage of voting rights 5.03 |
Published
25/05/2012 15:16
Contact
Phone 044 1737 837148 Email [email protected]
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Swedish Orphan Biovitrum
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 21
AGM Information
2026
May 6
AGM Information
2026
May 6
Interim / Quarterly Report
2026
Apr 28
Interim / Quarterly Report
2026
Apr 28
Annual Report
2026
Mar 31
Annual Report
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27